Shares of Molina Healthcare, Inc. (NYSE:MOH) have received an average rating of “Hold” from the seventeen brokerages that are currently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation, six have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $144.83.
MOH has been the topic of several recent research reports. Morgan Stanley lifted their target price on shares of Molina Healthcare from $180.00 to $192.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 13th. ValuEngine raised shares of Molina Healthcare from a “sell” rating to a “hold” rating in a research note on Wednesday, January 2nd. Stephens initiated coverage on shares of Molina Healthcare in a research note on Monday, January 14th. They set an “equal weight” rating and a $144.00 target price on the stock. Wolfe Research cut shares of Molina Healthcare from an “outperform” rating to a “market perform” rating in a research note on Thursday, January 3rd. Finally, Mitsubishi UFJ Financial Group raised shares of Molina Healthcare from a “neutral” rating to an “overweight” rating in a research note on Tuesday, January 8th.
NYSE MOH traded down $0.22 on Monday, hitting $120.46. The company had a trading volume of 21,282 shares, compared to its average volume of 1,118,800. Molina Healthcare has a 12-month low of $80.77 and a 12-month high of $154.06. The company has a debt-to-equity ratio of 0.74, a quick ratio of 1.52 and a current ratio of 1.52. The firm has a market cap of $7.76 billion, a PE ratio of 10.89, a PEG ratio of 0.97 and a beta of 1.68.
Molina Healthcare (NYSE:MOH) last announced its earnings results on Monday, February 11th. The company reported $3.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.52 by $2.36. Molina Healthcare had a net margin of 3.74% and a return on equity of 45.70%. The company had revenue of $4.66 billion for the quarter, compared to analysts’ expectations of $4.56 billion. On average, equities analysts predict that Molina Healthcare will post 9.92 EPS for the current fiscal year.
In other news, Director Ronna Romney sold 200 shares of the business’s stock in a transaction dated Friday, February 1st. The shares were sold at an average price of $132.72, for a total transaction of $26,544.00. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 0.77% of the company’s stock.
A number of hedge funds and other institutional investors have recently bought and sold shares of MOH. Financial Gravity Companies Inc. purchased a new stake in shares of Molina Healthcare during the fourth quarter worth approximately $51,000. Financial Gravity Wealth Inc. acquired a new position in Molina Healthcare in the first quarter valued at approximately $54,000. Cypress Capital Management LLC WY boosted its holdings in Molina Healthcare by 82.4% in the fourth quarter. Cypress Capital Management LLC WY now owns 602 shares of the company’s stock valued at $70,000 after purchasing an additional 272 shares in the last quarter. Advisory Services Network LLC acquired a new position in Molina Healthcare in the fourth quarter valued at approximately $103,000. Finally, MERIAN GLOBAL INVESTORS UK Ltd acquired a new position in Molina Healthcare in the fourth quarter valued at approximately $139,000.
Molina Healthcare Company Profile
Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.
Read More: How a Put Option Works
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.